C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2011
11/08/2011	US8053563 YKL-40 monoclonal authority
11/08/2011	US8053562 Modified antibody fragments
11/08/2011	US8053558 Dendritic cell co-stimulatory molecules
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8053554 Peptide nanostructures and methods of generating and using the same
11/08/2011	US8053551 Comprises six transmembrane epithelial antigen of the prostate-2 protein (STEAP)) for diagnosis and treatment of cell proliferative and tumor disorders; genetic vaccine; antitumor agents
11/08/2011	US8053414 Methods of using B7-DC molecules to induce or enhance an immune response
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053209 FRET protease assays for clostridial toxins
11/08/2011	US8053208 FRET protease assays for clostridial toxins
11/08/2011	US8053206 Antagonists of HMG1 for treating inflammatory conditions
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011	US8052972 Remedies for inflammatory bowel diseases
11/08/2011	CA2555688C Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies
11/08/2011	CA2443290C Neurovirulent strain of the west nile virus and applications thereof
11/08/2011	CA2442182C Modulation of pd-1 interactions with its ligands
11/08/2011	CA2436595C Chronic lymphocytic leukemia cell line and its use for producing an antibody
11/08/2011	CA2436180C Immunoregulatory antibodies and uses thereof
11/08/2011	CA2246352C Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
11/08/2011	CA2153692C Recombinant anti-vla4 antibody molecules
11/05/2011	CA2778690A1 Antibody mimetic scaffolds
11/03/2011	WO2011137395A1 Anti-c5a antibodies and methods for using the antibodies
11/03/2011	WO2011137362A1 Antibodies having reduced immunogenicity in a human
11/03/2011	WO2011136911A2 Anti-erbb3 antibodies
11/03/2011	WO2011136533A2 Chromatography apparatus and method
11/03/2011	WO2011136377A1 Antifreeze protein
11/03/2011	WO2011136332A1 Monoclonal antibody against slightly oxidized low-density lipoprotein and hybridoma for producing the same
11/03/2011	WO2011135869A1 Novel muc1 antibody
11/03/2011	WO2011135035A1 Immunoassay for chromogranin a, antibodies and kit
11/03/2011	WO2011135026A1 Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23
11/03/2011	WO2011134060A1 Anti-icam-1 single domain antibody and uses thereof
11/03/2011	WO2011108008A3 Antibody for targeted induction of apoptosis, cdc and adcc mediated killing of cancer cells, tbl-cln1
11/03/2011	WO2011104307A3 Ligands for antibody purification by affinity chromatography
11/03/2011	WO2011075606A3 Hyperglycosylated polypeptide variants and methods of use
11/03/2011	WO2011046623A3 Hiv-1 antibodies
11/03/2011	WO2011026132A8 Methods and compositions for the inhibition of transplant rejection
11/03/2011	WO2011022103A9 Ganglioside epitopes for treating guillain-barre syndrome
11/03/2011	WO2010115552A8 Bispecific anti-erbb-3/anti-c-met antibodies
11/03/2011	WO2010093993A3 Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
11/03/2011	US20110271401 Procedure for producing transgenic plants providing high starch content and yield and high amylose/amylopectin balance
11/03/2011	US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
11/03/2011	US20110271357 Colon disease targets and uses thereof
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110269942 Antibodies modified with hydrophobic molecule
11/03/2011	US20110269938 Amyloid-beta peptide crystal structure
11/03/2011	US20110269817 Compositions and methods related to sirt1 function
11/03/2011	US20110269814 2'-f modified rna interference agents
11/03/2011	US20110269797 Anln protein as an endocrine treatment predictive factor
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
11/03/2011	US20110269636 Materials and methods for identifying patients at heighten risk for developing her2+ related brain tumors
11/03/2011	US20110269152 Anchoring/capturing system for selecting or analyzing a CHO cell according to a product secreted by the CHO cell
11/03/2011	US20110269146 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
11/03/2011	US20110269141 Target protein and target gene for drug discovery, and screening method
11/03/2011	US20110269122 Hereditary hemochromatosis gene
11/03/2011	US20110268748 NURR-1 Interacting Protein (NuIP)
11/03/2011	US20110268746 Human cytomegalovirus neutralizing antibodies and use thereof
11/03/2011	US20110268745 Antibodies Against Tissue Factor Pathway Inhibitor (TFPI)
11/03/2011	US20110268744 Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
11/03/2011	US20110268742 Pctp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
11/03/2011	US20110268741 Immunotherapy for Contact Dermatitis Using Co-Signal Regulation
11/03/2011	US20110268740 Fully human influenza m2 specific antibodies
11/03/2011	US20110268739 Human binding molecules having killing activity against enterococci and uses thereof
11/03/2011	US20110268738 Antibodies Against Hmgb1 and Fragments Thereof
11/03/2011	US20110268735 Multimeric constructs
11/03/2011	US20110268734 Preventive or therapeutic agent for psoriatic arthritis comprising il-6 antagonist as active ingredient
11/03/2011	US20110268733 ANTI-Siglec-15 ANTIBODY
11/03/2011	US20110268729 Treatment of amyotrophic lateral sclerosis by nogo-a-antagonist
11/03/2011	US20110268728 Solubility optimization of immunobinders
11/03/2011	US20110268727 Anti-interferon-alpha antibodies
11/03/2011	US20110268726 Anti-CD38 human antibodies and uses thereof
11/03/2011	US20110268725 Anti-NGF antibodies for the treatment of various disorders
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268695 Use of hmgb fragments as anti-inflammatory agents
11/03/2011	US20110268670 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2011	US20110268656 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
11/03/2011	US20110268655 Anti-alpha v immunoliposome compositions, methods and uses
11/03/2011	CA2804976A1 Methods and compositions for treating hepatitis with anti-cd3 immune molecule therapy
11/03/2011	CA2800565A1 Anti-icam-1 single domain antibody and uses thereof
11/03/2011	CA2800292A1 Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23
11/03/2011	CA2797856A1 Anti-c5a antibodies and methods for using the antibodies
11/03/2011	CA2795799A1 Anti-erbb3 antibodies
11/02/2011	EP2383297A1 Optimized antibodies that target CD19
11/02/2011	EP2383296A1 Antibody for the thyrotropin receptor and uses thereof
11/02/2011	EP2383295A1 IP-10 antibodies and their uses
11/02/2011	EP2383294A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
11/02/2011	EP2383293A1 Immunoassay for Chromogranin A, antibodies and kit
11/02/2011	EP2383292A1 Improved fibronectin-based binding molecules and uses thereof
11/02/2011	EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2383288A2 Differential in tumour gene products and use of same
11/02/2011	EP2383287A1 Citrobacter rodentium secreted proteins
11/02/2011	EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/02/2011	EP2382990A1 Methods for treating cancer using an immunotoxin
11/02/2011	EP2382239A1 Tumor markers and methods of use thereof
11/02/2011	EP2382238A1 Anti-lymphotoxin antibodies
11/02/2011	EP2382234A2 Immunoglobulin variants with altered binding to protein a
11/02/2011	EP2381960A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents
11/02/2011	EP2381952A2 Sparc binding peptides and uses thereof
11/02/2011	EP2381934A2 Improving cognitive function

1 ... 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 ... 1494